File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Symptomatic Pneumonitis with Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer

TitleSymptomatic Pneumonitis with Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer
Authors
Vansteenkiste, Johan FNaidoo, JarushkaFaivre–Finn, CorinneÖzgüroğlu, MustafaVillegas, AugustoDaniel, DaveyMurakami, ShujiHui, RinaLee, Ki HyeongCho, Byoung ChulKubota, KaoruBroadhurst, HelenWadsworth, CatherineNewton, MichaelThiyagarajah, PirunthaAntonia, Scott J
Issue Date17-Jan-2024
PublisherElsevier
Citation
JTO Clinical and Research Reports, 2024 How to Cite?
DOI: http://dx.doi.org/10.1016/j.jtocrr.2024.100638
Persistent Identifierhttp://hdl.handle.net/10722/340099
ISSN
2666-3643

 

DC FieldValueLanguage
dc.contributor.authorVansteenkiste, Johan F-
dc.contributor.authorNaidoo, Jarushka-
dc.contributor.authorFaivre–Finn, Corinne-
dc.contributor.authorÖzgüroğlu, Mustafa-
dc.contributor.authorVillegas, Augusto-
dc.contributor.authorDaniel, Davey-
dc.contributor.authorMurakami, Shuji-
dc.contributor.authorHui, Rina-
dc.contributor.authorLee, Ki Hyeong-
dc.contributor.authorCho, Byoung Chul-
dc.contributor.authorKubota, Kaoru-
dc.contributor.authorBroadhurst, Helen-
dc.contributor.authorWadsworth, Catherine-
dc.contributor.authorNewton, Michael-
dc.contributor.authorThiyagarajah, Piruntha-
dc.contributor.authorAntonia, Scott J-
dc.date.accessioned2024-03-11T10:41:40Z-
dc.date.available2024-03-11T10:41:40Z-
dc.date.issued2024-01-17-
dc.identifier.citationJTO Clinical and Research Reports, 2024-
dc.identifier.issn2666-3643-
dc.identifier.urihttp://hdl.handle.net/10722/340099-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofJTO Clinical and Research Reports-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleSymptomatic Pneumonitis with Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer-
dc.typeArticle-
dc.identifier.doi10.1016/j.jtocrr.2024.100638-
dc.identifier.eissn2666-3643-
dc.identifier.issnl2666-3643-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats